Contraline, Inc.
Biotechnology company · Charlottesville, Virginia, United States
Contraline, Inc. is a biotechnology company headquartered in Charlottesville, Virginia, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $56 million sold in a notice filed in 2026.
Contraline at a glance
What does Contraline do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.4 million in total (2024 to 2025). NIH funding came from the National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $55.8 million sold (2026).
Frequently asked questions about Contraline
Where is Contraline headquartered?
Contraline, Inc. is headquartered in Charlottesville, Virginia, United States.
What does Contraline do?
Contraline, Inc. is a biotechnology company.
When was Contraline founded?
The earliest incorporation on record for Contraline, Inc. is in 2017, according to public company registers.
Similar companies
- Hemoshear Therapeutics, Inc.Charlottesville, Virginia, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.